TrialEuropean journal of nuclear medicine and molecular imaging2024

Intra-arterial peptide-receptor radionuclide therapy for neuro-endocrine tumour liver metastases: an in-patient randomised controlled trial (LUTIA).

S C Ebbers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.